Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions.

Table of Contents


Front Matter
1 Introduction
2 A Lesson About Precompetitive Collaboration
3 Requisites for Successful Precompetitive Collaboration
4 Frameworks for Collaboration
5 The Use of Biospecimens in Precompetitive Collaborations
6 Ethical Challenges in the Use of Biospecimens
7 Toward Developing a Cultural, Legal, and Behavioral Framework for Precompetitive Collaboration
References
Appendix A: Workshop Agenda
Appendix B: Speaker Biographical Sketches